Valeritas (NSDQ:VLRX) touted data today from an analysis showing that insulin-dependent people with Type 2 diabetes benefited from using the company’s wearable V-Go insulin delivery device. The study featured people who previously treated their diabetes using multiple daily injections of insulin. After switching to the V-Go device under the care of advanced practitioners, participants were monitored […]
Diabetes
Dexcom beats the Street with Q2 results
Dexcom (NSDQ:DXCM) topped sales and earnings expectations on Wall Street today with its second-quarter financial results. The San Diego, Calif.-based company posted profits of $30.2 million, or 34¢ per share, on sales of $242.5 million for the three months ended June 30, representing a whopping 941% increase in profits and a 42% increase in sales compared […]
Nemaura touts data from home-use study of wearable glucose monitor
Nemaura Medical (NSDQ:NMRD) said today that it launched a study of its wearable glucose monitor in the hopes of winning regulatory approval in the U.S. The England-based company touted positive interim data from the study, focusing on the at-home use of the sugarBeat device. The company’s interim results included findings from 25 patients with either Type […]
Valeritas launches V-Go insulin delivery device in New Zealand
Valeritas (NSDQ:VLRX) said today that its V-Go wearable insulin delivery device is now available in New Zealand thanks to an exclusive distribution deal with NZMS Diabetes. According to the terms of the agreement, Valeritas will be responsible for product development, regulatory approval, manufacturing and quality management while NZMS Diabetes will take over the sales, marketing, customer […]
Tandem posts mixed Q2 results
Shares in Tandem Diabetes Care (NSDQ:TNDM) fell this week after the insulin pump maker topped sales expectations but missed earnings estimates on Wall Street with its second-quarter financial results. The San Diego, Calif.-based company posted a net loss of -$59.4 million on sales of $34.1 million for the 3 months ended June 30, for sales growth of […]
SFC Fluidics lands JDRF support for interoperable insulin patch pump
SFC Fluidics said today that it inked a deal with JDRF to support the development of an insulin patch pump with open-protocol communication features. SFC Fluidics plans to use the two-year funding deal from JDRF to speed up the development of a patch pump that securely connects with other devices, like a continuous glucose monitor […]
Abbott wins FDA nod for 14-day FreeStyle Libre glucose sensor
Abbott (NYSE:ABT) said today that the FDA approved its 14-day FreeStyle Libre flash glucose monitor, making the device the longest lasting self-applied glucose sensor on the market. The company’s FreeStyle Libre system, initially approved to last 10 days, is designed to eliminate the need for fingersticks. Users can test their blood sugar with the continuous glucose […]
Novo Nordisk exec: In the digital age, it’s not enough to have a better molecule
Much of Dr. Todd Hobbs’ life has centered around diabetes – he was diagnosed with Type I diabetes roughly 30 years ago and now he is the father of a child with diabetes. At his Kentucky-based primary care practice, he took on diabetic patients and helped manage their care. And when he made the jump […]
Going public, Provention Bio looks to tackle immune-mediated diseases
Shares in Oldwick, N.J.-based Provention Bio began trading today following the close of its $64 million initial public offering last week. The biopharmaceutical company, lead by co-founder & CEO Ashleigh Palmer, is developing a number of products that aim to prevent or stop the spread of immune-mediated diseases, including Lupus, Crohn’s disease and Type I diabetes. […]
Companion Medical wins CE Mark for InPen insulin pen
Companion Medical said yesterday that it won CE Mark approval in the European Union for its InPen smart insulin pen and associated diabetes management smartphone application. The company’s InPen system consists of a smart insulin injection pen that connects with an integrated diabetes management app. The InPen application displays aggregated glucose, insulin and meal data and […]